机构ID,机构名称,公告日期,开始日期,截止日期,报告年度,合并类型,报表来源,一、营业总收入,其中：营业收入（元）,二、营业总成本,其中：营业成本,营业税金及附加,销售费用,管理费用,堪探费用,财务费用,资产减值损失,加：公允价值变动净收益,投资收益,其中：对联营企业和合营企业的投资收益,汇兑收益,影响营业利润的其他科目,三、营业利润,加：补贴收入,营业外收入,减：营业外支出,其中：非流动资产处置损失,加：影响利润总额的其他科目,四、利润总额,减：所得税,加：影响净利润的其他科目,五、净利润,归属于母公司所有者的净利润,少数股东损益,六、每股收益：,（一）基本每股收益,（二）稀释每股收益,七、其他综合收益,八、综合收益总额,其中：归属于母公司,其中：归属于少数股东,利息收入,已赚保费,手续费及佣金收入,利息支出,手续费及佣金支出,退保金,赔付支出净额,提取保险合同准备金净额,保单红利支出,分保费用,其中：非流动资产处置利得
300519,新光药业,2016-06-06,2016-01-01,2016-03-31,2016-03-31,合并本期,招募说明书,94790675.47,94790675.47,31323416.01,31323416.01,1400260.83,8688418.69,7938462.3,,-181266.98,-922223.34,,,,,0.0,46543607.96,,29648.15,88393.69,,0.0,46484862.42,6709570.17,0.0,39775292.25,39775292.25,,,,,-1490470.94,38284821.31,38284821.31,,,,,,,,,,,,
300519,新光药业,2016-08-02,2016-01-01,2016-06-30,2016-06-30,合并本期,定期报告,156028617.69,156028617.69,53323230.36,53323230.36,1856349.69,17806934.11,18758770.64,,-307886.38,-527504.9,,240000.0,,,,65358724.13,,1465270.78,131006.83,,,66692988.08,9646828.33,,57046159.75,57046159.75,,,0.9508,0.9508,-1149421.24,55896738.51,55896738.51,,,,,,,,,,,,
300519,新光药业,2016-10-28,2016-01-01,2016-09-30,2016-09-30,合并本期,定期报告,229845114.22,229845114.22,79049288.63,79049288.63,2851563.49,26974300.88,24953448.16,,-917606.96,-347253.01,,339833.28,,,,97621206.31,,1580266.43,183539.83,,,99017932.91,14495142.61,,84522790.3,84522790.3,,,1.27,1.27,-1112834.26,83409956.04,83409956.04,,,,,,,,,,,,
300519,新光药业,2017-04-18,2016-01-01,2016-12-31,2016-12-31,合并本期,定期报告,315313658.27,315313658.27,109536212.55,109536212.55,5425588.44,36186725.25,34063698.62,,-1373426.07,168044.51,,706749.8,,,,132013564.77,,6740594.68,215087.5,18556.45,,138539071.95,19580278.93,,118958793.02,118958793.02,,,1.7,1.7,-1306583.47,117652209.55,117652209.55,,,,,,,,,,,,
300519,新光药业,2017-04-26,2017-01-01,2017-03-31,2017-03-31,合并本期,定期报告,85675588.73,85675588.73,32011130.02,32011130.02,1026665.29,7105593.06,9505680.43,,-1248777.37,-964603.36,,853786.51,,,,39093687.17,,342295.65,,,,39435982.82,5923788.81,,33512194.01,33512194.01,,,0.42,0.42,-15621.18,33496572.83,33496572.83,,,,,,,,,,,,
300519,新光药业,2017-08-15,2017-01-01,2017-06-30,2017-06-30,合并本期,定期报告,150778557.68,150778557.68,57905897.28,57905897.28,2895183.94,16171660.83,18635749.98,,-1595405.81,-613998.21,,1878634.93,,,,59258104.6,,469841.3,,,,59727945.9,8341196.71,,51386749.19,51386749.19,,,0.64,0.64,-423898.81,50962850.38,50962850.38,,,,,,,,,,,,
